EKSO Q3 2023 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$5M+38.4% YoY

Gross Profit

$2M53.3% margin

Operating Income

-$3M-63.6% margin

Net Income

-$3M-73.0% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

-2.0%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$526,000

Balance Sheet

Total Assets

$31M

Total Liabilities

$16M

Stockholders' Equity

$15M

Cash & Equivalents

$10M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$3M	+38.4%
Gross Profit	$2M	$2M	+45.7%
Operating Income	-$3M	-$4M	+19.8%
Net Income	-$3M	-$4M	+21.8%

Revenue Segments

Product

$4M78%

Service

$726,00016%

Subscription

$245,0005%

Product and Service, Other

$56,0001%

Geographic Segments

Americas

$3M35%

UNITED STATES

$3M34%

EMEA

$1M11%

EMEA Other

$527,0006%

POLAND

$496,0005%

Asia Pacific

$324,0004%

HONG KONG

$178,0002%

APAC Other

$146,0002%

Americas Other

$138,0001%

GERMANY

$23,0000%